Contact Us | Visit imshealth.com | Français

Solutions for You to Drive Healthcare Forward

Enhanced Tumour Studies (ETS)

Enhanced Tumour Studies (ETS) is a syndicated report supporting insights into prescribing and utilization patterns for Oncology markets in Canada.  The reports are generated on a robust sample of patient record data which answer strategic business questions including but not limited to:

  • Product and regimen share by stage and diagnosis intent
  • Line of therapy
  • Duration of therapy
  • Demographic splits
  • ECOG status
  • Testing and surgery information
  • Co-morbidities, etc. 

The reporting provides a complete picture of the patients treatment with  both oral and IV treatment represented.  ETS will also include a complete picture of treatment choices in Canada including Clinical trial information.  Since the sampling is distributed across Canada, a complete and accurate representation of treatment patterns are presented without bias of decisions made by regional/provincial Cancer Boards or hospitals.  Analysis can be customized to your requirements to answer specific business questions. 

Fact Sheet

Click on the Icon to
Download the FacT Sheet

Market Insights

Privacy   |   Terms of Use    Copyright © 2016 IMS Health Incorporated. All rights reserved.